National Press Club
Holeman Lounge, 13th floor
529 14th St. NW, Washington, D.C.
Wednesday, November 1, 2017
12 PM – 4 PM
Dusty Donaldson, co-chair, Lung Cancer Action Network (LungCAN), Lung Cancer Survivor and Advocate
Dr. Fred Hirsch, MD; CEO, International Association for the Study of Lung Cancer
Melissa Culligan, RN, MS; University of Maryland School of Medicine, Director of Clinical Research, Division of Thoracic Surgery; and Chair, Int’l. Thoracic Oncology Nursing Forum
Jennifer King, PhD; Director of Science and Research, Lung Cancer Alliance
John F.P. Bridges, PhD; Associate Professor, Johns Hopkins Bloomberg School of Public Health
David LeDuc, CEO, Addario Lung Cancer Foundation
Paul Billings, SVP of Advocacy, American Lung Association
K Latzka, Survivor & Advocate – Co-Organizer of Life & Breath Rally Nov. 2
Jackie Nixon, Survivor and Advocate
Montessa Lee, Survivor and Advocate
Laurie Fenton-Ambrose, President & CEO, Lung Cancer Alliance
Andrea Ferris, CEO, Lungevity
Kyle Hoylman, President, Cancer Survivors Against Radon (CanSAR)
PRESS CONFERENCE SCHEDULE
Lunch (30 min)
Guests will be served lunch before the panel sessions begin.
Welcoming remarks (10 min) – Fred Hirsch, MD, PhD, CEO of IASLC
Moderator introduction (5 min) – Dusty Donaldson
Panel 1: Future of Lung Cancer Research & Treatment (30 minutes)
The panel’s section will focus on a forward-looking discussion about what is next for the lung cancer advocacy community and how the month’s objectives push that mission ahead. A five minute Q&A will follow the panel.
- Potential panel perspectives to include in the discussion:
- Physician– New technologies or research to help diagnosis or treatment
- Researcher – Importance of Psycho-social research in lung cancer survivorship
- Nurse – Perspectives on clinical trials and patient management
- Advocate – New tactics and messages for awareness that can grow the base of supporters and combat stigma (or other relevant topic)
- Survivor – Growing the number and community of survivors
- Survivor – How they were helped/impacted by clinical trials and/or screening
Panel 2: Future of Lung Cancer Advocacy
Misinformation and Stigma; Involving Advocates in Research, Patient-Led Activities (GG/Dusty, you can improve this description.) A five minute Q&A will follow the panel.
- Physician – How physicians can advocate and support patient advocacy
- Researcher – Patients involved in research
- Advocate – How public ignorance makes advocacy difficult but also more important (or other relevant topic)
- Survivor – The difficulties of having a disease with stigma; the triumph of surviving such a disease
- Survivor – K Latzka, Life & Breath Rally on Nov. 2nd
Concluding remarks (3 min)
Networking reception (30 min)
Guests will be able to network one another, meet with the panelists, and connect on advocacy and issues.
We rely on the generous support of several corporate partners. Special thanks to all our supporters.